Phathom Pharmaceuticals, Inc. Current Ratio in % from Q2 2020 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Phathom Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q2 2020 to Q3 2025.
  • Phathom Pharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2025 was 305 %, a 58.1% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)

Phathom Pharmaceuticals, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 305 -423 -58.1% Sep 30, 2025
Q2 2025 384 -444 -53.6% Jun 30, 2025
Q1 2025 479 -477 -49.9% Mar 31, 2025
Q4 2024 571 -464 -44.8% Dec 31, 2024
Q3 2024 728 -182 -20% Sep 30, 2024
Q2 2024 828 -59.8 -6.74% Jun 30, 2024
Q1 2024 957 +121 +14.4% Mar 31, 2024
Q4 2023 1.03K +160 +18.3% Dec 31, 2023
Q3 2023 910 -85.1 -8.55% Sep 30, 2023
Q2 2023 888 -80 -8.27% Jun 30, 2023
Q1 2023 836 +49.1 +6.25% Mar 31, 2023
Q4 2022 874 +193 +28.4% Dec 31, 2022
Q3 2022 995 +403 +68% Sep 30, 2022
Q2 2022 968 +374 +62.9% Jun 30, 2022
Q1 2022 787 +51.1 +6.94% Mar 31, 2022
Q4 2021 681 -338 -33.2% Dec 31, 2021
Q3 2021 593 -1.42K -70.6% Sep 30, 2021
Q2 2021 594 +226 +61.4% Jun 30, 2021
Q1 2021 736 Mar 31, 2021
Q4 2020 1.02K Dec 31, 2020
Q3 2020 2.02K Sep 30, 2020
Q2 2020 368 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.